Cargando…
Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis
BACKGROUND: Praziquantel has been used as first-line drug for chemotherapy of schistosomiasis since 1984. Besides praziquantel, artemether and artesunate have also been used for the control of this infectious disease since late 1990s. In this article, we conducted a systematic review and meta-analys...
Autores principales: | Liu, Rong, Dong, Hui-Fen, Guo, Yi, Zhao, Qin-Ping, Jiang, Ming-Sen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207908/ https://www.ncbi.nlm.nih.gov/pubmed/22004571 http://dx.doi.org/10.1186/1756-3305-4-201 |
Ejemplares similares
-
An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent
por: Dong, Lanlan, et al.
Publicado: (2014) -
Efficacy of Praziquantel for the Treatment of Human Schistosomiasis in Ethiopia: A Systematic Review and Meta-Analysis
por: Hailegebriel, Tamirat, et al.
Publicado: (2021) -
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023) -
Systematic Review and Meta-Analysis of Artemisinin Based Therapies for the Treatment and Prevention of Schistosomiasis
por: Pérez del Villar, Luis, et al.
Publicado: (2012) -
The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review
por: Niu, Xuehua, et al.
Publicado: (2022)